Lab
Coreplus Servicios Clinicos Y Patologicos LLC
Coreplus Servicios Clinicos Y Patologicos LLC was paid $13.04M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 18% of everything it billed.
33Billing provider infoCOREPLUS SERVICIOS CLINICOS Y PATOLOGICOS LLC
CAROLINA, PR 00983
CAROLINA, PR 00983
33aNPI1780830737assigned 08/11/2008
33bProvider typeClinical Medical Laboratory
28Total paid$13.04M
24GClaims405,943
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#5 of 777
Median peer was paid$278K
This provider vs. median47×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,242 | $533K | |
| 2019 | 19,630 | $714K | |
| 2020 | 55,421 | $1.49M | |
| 2021 | 74,821 | $2.25M | |
| 2022 | 66,972 | $1.99M | |
| 2023 | 94,554 | $2.96M | |
| 2024incomplete | 77,303 | $3.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 18% | 17,240 | 14,099 | $2.39M |
| 88312 | 12% | 13,105 | 11,128 | $1.61M | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 10% | 36,637 | 32,502 | $1.36M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.2% | 23,806 | 20,590 | $1.07M |
| 88142 | 6.5% | 41,468 | 36,101 | $844K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.5% | 25,628 | 22,385 | $842K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.4% | 25,782 | 22,510 | $829K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.8% | 7,742 | 6,701 | $370K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.6% | 9,946 | 8,859 | $339K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.5% | 15,671 | 13,271 | $329K |
| 87529 | 2.0% | 5,375 | 4,233 | $267K | |
| 88112 | 1.7% | 4,653 | 3,963 | $217K |
80 more codes
| 88341 | 1.3% | 982 | $175K | |
| 88108 | 1.3% | 4,077 | $167K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 6,676 | $159K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.2% | 4,194 | $154K |
| 88304 | 1.1% | 4,641 | $149K | |
| 87490 | <1% | 6,551 | $129K | |
| 87590 | <1% | 6,500 | $128K | |
| 88342 | <1% | 1,514 | $121K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,860 | $119K |
| 80061 | Lipid panel | <1% | 9,742 | $111K |
| 86328 | <1% | 7,040 | $106K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,900 | $99K |
| 88141 | <1% | 4,464 | $82K | |
| 86738 | <1% | 6,725 | $80K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,121 | $80K |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | <1% | 267 | $78K |
| 80053 | Comprehensive metabolic panel | <1% | 11,253 | $75K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,088 | $59K |
| 88311 | <1% | 3,286 | $55K | |
| 87070 | <1% | 5,395 | $52K | |
| 88173 | <1% | 275 | $41K | |
| 82274 | <1% | 2,521 | $34K | |
| 81000 | <1% | 10,517 | $33K | |
| 80050 | General health panel | <1% | 3,244 | $29K |
| 87081 | <1% | 3,748 | $27K | |
| 88313 | <1% | 633 | $21K | |
| 84153 | <1% | 1,287 | $20K | |
| 84439 | <1% | 2,155 | $17K | |
| 84436 | <1% | 2,859 | $16K | |
| 82043 | <1% | 2,532 | $12K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 214 | $12K |
| 88150 | <1% | 1,904 | $12K | |
| 87088 | <1% | 1,476 | $11K | |
| 84479 | <1% | 2,331 | $10K | |
| 87147 | <1% | 2,568 | $9K | |
| 81001 | <1% | 3,053 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,000 | $7K |
| 82607 | <1% | 531 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 965 | $7K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 319 | $6K |
| 86701 | <1% | 733 | $6K | |
| 80074 | <1% | 116 | $5K | |
| 86592 | <1% | 1,320 | $5K | |
| 88360 | <1% | 55 | $5K | |
| 85730 | <1% | 796 | $4K | |
| 86038 | <1% | 379 | $4K | |
| 86696 | <1% | 189 | $4K | |
| 85651 | <1% | 1,116 | $4K | |
| 86140 | <1% | 720 | $3K | |
| 88143 | <1% | 225 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 618 | $3K |
| 85610 | <1% | 831 | $3K | |
| 87186 | <1% | 389 | $3K | |
| 87181 | <1% | 347 | $3K | |
| 82570 | <1% | 530 | $2K | |
| 88302 | <1% | 43 | $2K | |
| 86695 | <1% | 101 | $1K | |
| 86803 | <1% | 101 | $1K | |
| 86703 | <1% | 107 | $1K | |
| 84703 | <1% | 171 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 23 | $1K |
| 83001 | <1% | 51 | $858.00 | |
| 86431 | <1% | 164 | $789.68 | |
| 84403 | <1% | 34 | $646.55 | |
| 85652 | <1% | 143 | $317.68 | |
| 83655 | <1% | 32 | $286.27 | |
| 84481 | <1% | 19 | $279.18 | |
| 82270 | <1% | 103 | $268.88 | |
| 83002 | <1% | 13 | $228.88 | |
| 82950 | <1% | 67 | $201.66 | |
| 82728 | <1% | 14 | $190.80 | |
| 80076 | <1% | 29 | $163.79 | |
| 85027 | <1% | 14 | $77.76 | |
| 84550 | <1% | 12 | $45.97 | |
| 0001A | 0% | 61 | $0.00 | |
| 86357 | 0% | 29 | $0.00 | |
| 0002A | 0% | 55 | $0.00 | |
| 87899 | 0% | 674 | $0.00 | |
| 86359 | 0% | 29 | $0.00 | |
| 86360 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDE SOCARRAZ, MARIANO (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Coreplus Servicios Clinicos Y Patologicos LLC | Ponce, PR | $799K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.